← Open Payments lookup

JAMIE BREWER: Open Payments

NPI 1154733392 · FLORENCE, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,276 in 110 payments from 24 companies in 2025. Trend: 2023 $1,419 · 2024 $1,682 · 2025 $2,276

Food & beverage: $2,276
CompanyPaymentsAmount
Dexcom, Inc.8$271
Corcept Therapeutics18$271
Bayer Healthcare Pharmaceuticals Inc.10$218
Novo Nordisk Inc13$217
Astellas Pharma US Inc5$193
Lilly USA, LLC10$178
Tandem Diabetes Care, Inc.9$128
Xeris Pharmaceuticals, Inc.5$114
RGH Enterprises LLC1$93
Esperion Therapeutics, Inc.5$78

Products named: Dexcom G6 Transmitter, Korlym, Kerendia, Veozah, MOUNJARO, t:slim X2 Insulin Pump with Control-IQ, RECORLEV, NEXLETOL.

Industry payments across MS — which companies pay providers there.